Afr J Biotechnol 10:634863 Cuadrado A, Garcia-Fernandez LF, Gonzalez L, Suarez Y, Losada A, Alcaide V, Martinez T, Fernandez-Sousa JM, Sanchez-Puelles JM, Munoz A (2003) Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK
What doesn't exist is Phase III obesity trial data, long-term weight maintenance outcomes, or head-to-head comparisons with approved therapies
Individual outcomes vary
Retrieved 5 April 2024
This is done to reduce gastrointestinal side effects, the FDA said
This Phase III backup results in a buildup of oxidized waste-products known as free-radicals that damage cells, cause inflammation and other disease processes